Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Intralesional Injection of Pentoxifylline, Platelet-Rich Plasma, and Combined

NCT06319768 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT06319768
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06319768 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Intralesional Injection of Pentoxifylline, Platelet-Rich Plasma, and Combined
Lead sponsor
Sohag University
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2024
Completion date
June 15, 2024
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrophic acne scar